Reply from the Authors
Dear Editor, Restless legs syndrome (RLS) is a chronic, progressive sensorimotor neurologic condition (1) . In some recent studies, RLS has been associated with inflammatory diseases such as rheumatoid arthritis, systemic lupus, Crohn's disease, and celiac disease (2, 3) , and the possible role of inflammation in the etiology is discussed. Hypoxia-inducible factor-1 alpha (HIF-1a) acts as a regulator in inflammation (4) . In a study by Patton et al. (5) , high HIF-1a values were shown in the substantia nigra neurons of patients with RLS, indicating the role of inflammation at the cellular level in RLS. The neutrophil-to-lymphocyte ratio (NLR) and platelet-tolymphocyte ratio (PLR) are low cost and easily applicable methods that have recently been studied as markers of inflammation in various studies. The NLR has been evaluated in a number of central and systemic neurologic diseases such as ischemic and hemorrhagic cerebrovascular diseases, myasthenia gravis, and multiple sclerosis, and its association with prognosis has been shown (2,3). The NLR was found to be significantly higher in the RLS group and the effect of inflammation in the etiology was discussed in a single study evaluating inflammation with NLR in the literature (3) . In this study, we aimed to evaluate the possible inflammation with NLR and PLR in RLS, which is considered as a chronic neurologic condition, and the role of inflammation in the etiology of these diseases, and to discuss whether they may be biomarkers in terms of inflammation in neurologic diseases.
